PURPOSE: MRI is increasingly used for the detection of breast carcinoma. Little is known about breast MRI techniques among community practice facilities. The aim of this study was to evaluate equipment and acquisition techniques used by community facilities across the United States, including compliance with minimum standards by the ACRIN® 6667 Trial and the European Society of Breast Imaging. METHODS: Breast Cancer Surveillance Consortium facilities performing breast MRI were identified and queried by survey regarding breast MRI equipment and technical parameters. Variables included scanner field strength, coil type, acquisition coverage, slice thickness, and the timing of the initial postcontrast sequence. Results were tallied and percentages of facilities meeting ACRIN® and European Society of Breast Imaging standards were calculated. RESULTS: From 23 facilities performing breast MRI, results were obtained from 14 (61%) facilities with 16 MRI scanners reporting 18 imaging parameters. Compliance with equipment recommendations of ≥1.5-T field strength was 94% and of a dedicated breast coil was 100%. Eighty-three percent of acquisitions used bilateral postcontrast techniques, and 78% used slice thickness≤3 mm. The timing of initial postcontrast sequences ranged from 58 seconds to 8 minutes 30 seconds, with 63% meeting recommendations for completion within 4 minutes. CONCLUSIONS: Nearly all surveyed facilities met ACRIN and European Society of Breast Imaging standards for breast MRI equipment. The majority met standards for acquisition parameters, although techniques varied, in particular for the timing of initial postcontrast imaging. Further guidelines by the ACR Breast MRI Accreditation Program will be of importance in facilitating standardized and high-quality breast MRI.
PURPOSE: MRI is increasingly used for the detection of breast carcinoma. Little is known about breast MRI techniques among community practice facilities. The aim of this study was to evaluate equipment and acquisition techniques used by community facilities across the United States, including compliance with minimum standards by the ACRIN® 6667 Trial and the European Society of Breast Imaging. METHODS:Breast Cancer Surveillance Consortium facilities performing breast MRI were identified and queried by survey regarding breast MRI equipment and technical parameters. Variables included scanner field strength, coil type, acquisition coverage, slice thickness, and the timing of the initial postcontrast sequence. Results were tallied and percentages of facilities meeting ACRIN® and European Society of Breast Imaging standards were calculated. RESULTS: From 23 facilities performing breast MRI, results were obtained from 14 (61%) facilities with 16 MRI scanners reporting 18 imaging parameters. Compliance with equipment recommendations of ≥1.5-T field strength was 94% and of a dedicated breast coil was 100%. Eighty-three percent of acquisitions used bilateral postcontrast techniques, and 78% used slice thickness≤3 mm. The timing of initial postcontrast sequences ranged from 58 seconds to 8 minutes 30 seconds, with 63% meeting recommendations for completion within 4 minutes. CONCLUSIONS: Nearly all surveyed facilities met ACRIN and European Society of Breast Imaging standards for breast MRI equipment. The majority met standards for acquisition parameters, although techniques varied, in particular for the timing of initial postcontrast imaging. Further guidelines by the ACR Breast MRI Accreditation Program will be of importance in facilitating standardized and high-quality breast MRI.
Authors: Francesco Sardanelli; Gian M Giuseppetti; Pietro Panizza; Massimo Bazzocchi; Alfonso Fausto; Giovanni Simonetti; Vincenzo Lattanzio; Alessandro Del Maschio Journal: AJR Am J Roentgenol Date: 2004-10 Impact factor: 3.959
Authors: Judy M Destouet; Lawrence W Bassett; Martin J Yaffe; Priscilla F Butler; Pamela A Wilcox Journal: J Am Coll Radiol Date: 2005-07 Impact factor: 5.532
Authors: Mitchell D Schnall; Jeffery Blume; David A Bluemke; Gia A Deangelis; Nanette Debruhl; Steven Harms; Sylvia H Heywang-Köbrunner; Nola Hylton; Christiane K Kuhl; Etta D Pisano; Petrina Causer; Stuart J Schnitt; Stanley F Smazal; Carol B Stelling; Constance Lehman; Paul T Weatherall; Constantine A Gatsonis Journal: J Surg Oncol Date: 2005-10-01 Impact factor: 3.454
Authors: Elizabeth A Morris; Laura Liberman; Douglas J Ballon; Mark Robson; Andrea F Abramson; Alexandra Heerdt; D David Dershaw Journal: AJR Am J Roentgenol Date: 2003-09 Impact factor: 3.959
Authors: K Schelfout; M Van Goethem; E Kersschot; C Colpaert; A M Schelfhout; P Leyman; I Verslegers; I Biltjes; J Van Den Haute; J P Gillardin; W Tjalma; J C Van Der Auwera; P Buytaert; A De Schepper Journal: Eur J Surg Oncol Date: 2004-06 Impact factor: 4.424
Authors: Constance D Lehman; Constantine Gatsonis; Christiane K Kuhl; R Edward Hendrick; Etta D Pisano; Lucy Hanna; Sue Peacock; Stanley F Smazal; Daniel D Maki; Thomas B Julian; Elizabeth R DePeri; David A Bluemke; Mitchell D Schnall Journal: N Engl J Med Date: 2007-03-28 Impact factor: 91.245
Authors: S G Orel; M D Schnall; C M Powell; M G Hochman; L J Solin; B L Fowble; M H Torosian; E F Rosato Journal: Radiology Date: 1995-07 Impact factor: 11.105
Authors: Christoph I Lee; Laura Ichikawa; Michele C Rochelle; Karla Kerlikowske; Diana L Miglioretti; Brian L Sprague; Wendy B DeMartini; Karen J Wernli; Bonnie N Joe; Bonnie C Yankaskas; Constance D Lehman Journal: Acad Radiol Date: 2014-08-07 Impact factor: 3.173
Authors: Courtney K Morrison; Leah C Henze Bancroft; Wendy B DeMartini; James H Holmes; Kang Wang; Ryan J Bosca; Frank R Korosec; Roberta M Strigel Journal: Invest Radiol Date: 2017-04 Impact factor: 6.016
Authors: Roberta M Strigel; Jennifer Rollenhagen; Elizabeth S Burnside; Mai Elezaby; Amy M Fowler; Frederick Kelcz; Lonie Salkowski; Wendy B DeMartini Journal: Acad Radiol Date: 2016-12-13 Impact factor: 3.173
Authors: Hajar Kadivar; Barbara A Goff; William R Phillips; C Holly A Andrilla; Alfred O Berg; Laura-Mae Baldwin Journal: J Gen Intern Med Date: 2013-08-14 Impact factor: 5.128
Authors: Roberta M Strigel; Erin Bravo; Amye J Tevaarwerk; Bethany M Anderson; Amy L Stella; Heather B Neuman Journal: Clin Breast Cancer Date: 2020-10-17 Impact factor: 3.225